Blockchain Registration Transaction Record
BioStem Technologies to Report Q1 2026 Results on May 14
BioStem Technologies (BSEM) announces Q1 2026 financial results release on May 14, 2026, with a conference call and webcast at 4:30 PM ET. Learn about the company's regenerative medicine allografts and growth.
This news matters because BioStem Technologies is at the forefront of regenerative medicine, developing allografts that could revolutionize treatments for tissue repair and chronic wounds. Investors and healthcare professionals should monitor these results as they reflect the company's financial health and progress in bringing innovative therapies to market, potentially impacting patient outcomes and the broader medical landscape.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0xd1dc95955ede0381d02161c501378387a7e9efa8e5a719b24c0240ab4141e424 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | roamL9i3-eb75c841bc131c23eee22dec21a0e7d0 |